Clinical Trials Directory

Trials / Completed

CompletedNCT00281476

The Effect of High Dose Simvastatine on Multiple Myeloma

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Vejle Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the effect of high doses of Simvastatine on bone metabolisme and biochemical markers of disease in Multiple Myeloma

Conditions

Interventions

TypeNameDescription
DRUGSimvastatine

Timeline

Start date
2006-02-01
Completion
2007-11-01
First posted
2006-01-24
Last updated
2011-11-01

Source: ClinicalTrials.gov record NCT00281476. Inclusion in this directory is not an endorsement.